Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation

Type 2 diabetes (T2D) is an independent risk factor of stroke and systemic embolism in patients with atrial fibrillation (AF), and T2D patients with AF-associated stroke seem to have worse clinical outcome and higher risk of unfavorable clinical course compared to individuals without this metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Prídavková, Dana, Samoš, Matej, Bolek, Tomáš, Škorňová, Ingrid, Žolková, Jana, Kubisz, Peter, Staško, Ján, Mokáň, Marián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925766/
https://www.ncbi.nlm.nih.gov/pubmed/31886279
http://dx.doi.org/10.1155/2019/5158308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925766/
https://www.ncbi.nlm.nih.gov/pubmed/31886279
http://dx.doi.org/10.1155/2019/5158308

Ejemplares similares